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Lifestyle interventions (LIs) can treat metabolic syndrome and 
reduce the incidence of type 2 diabetes mellitus (T2DM) in high-risk 
individuals.[1] However, realising the health benefits of LIs in routine 
clinical practice remains elusive.[2] In January 2010, an LI model was 
created in a rural primary care practice and spread to four other 
rural communities. We present changes in health indicators among 
participants in two physician-led interventions.
Methods
Ethics approval was obtained from the Northern Health Authority 
and the University of British Columbia (Ref. no. H10-02573), 
Canada. The intervention was open to both individuals wanting to 
lose weight and those interested in a non-pharmacological approach 
to managing insulin resistance. The foundation of the intervention 
model was group medical visits, with 15 - 25 participants overseen 
by a clinical facilitator.
The clinically facilitated meetings featured a presentation germane 
to living a healthier lifestyle, such as sugar addiction, medication 
management, maintaining adherence while on vacation, etc. The 
remainder of the meeting time was used to answer participants’ 
questions and address experiences relating to living a healthier 
lifestyle. At the first site (S1), programme length was determined by 
participants’ progress towards their health goals. At the second site 
(S2), the intervention was 3 months in length. Individuals requiring 
additional support were encouraged to form peer-led support groups 
on their own initiative.
A quality improvement process whereby various lifestyle pre-
scriptions were tested with different groups was used to refine the 
intervention at S1. Results from these non-randomised ‘trials’ were 
tracked using local electronic medical record data. The outcome of this 
process was an intervention featuring a two-stage diet programme. 
The weight-loss diet restricted calories to approximately 1 100 and 
1 500 kcal/day for women and men, respectively; participants were 
instructed to avoid foods containing sugar and other refined carbo-
hydrates, in addition to restricting the consumption of dietary fat. 
To assist in appetite control, participants were instructed not to 
undertake moderate or vigorous physical activity until they had 
reached their weight-loss goal. After reaching their target weight, a 
high-fat diet was used for weight maintenance. The use of a high-fat 
diet was predicated on the high prevalence of insulin resistance in 
the patient population and favourable changes in multiple health 
indicators in randomised trials of up to 2 years’ duration in such 
populations.[3] Foods consumed on the maintenance diet included 
beef, poultry, fish, eggs, oils, moderate amounts of hard cheeses, and 
small amounts of nuts, nut butters, seeds and berries.
Measurements
Height was measured using a stadiometer, with participants wearing 
no shoes. Waist circumference was measured with a flexible tape 
measure and with the help of another participant. Weight was 
measured at every group visit with participants wearing light indoor 
clothing. Participants completed the PHQ-9 questionnaires to assess 
their mood. Scores on the PHQ-9 range from 0 (absence of depressive 
symptoms) to 27 (severe depressive symptoms). A score of ≥10 on the 
PHQ-9 was used to indicate depression.
Evaluation rationale, data extraction and  
statistical analyses
Following the success of the intervention at S1, the intervention 
model spread to four other rural communities. The intervention was 
created in 2010 by a physician (SDT) working in a service contract 
environment and was adopted into the practices of four fee-for-service 
physicians, a nurse practitioner and two registered nurses. The initial 
evaluation was planned to document health changes at S1, but owing 
to the unanticipated spread of the intervention, weight-loss results 
were included in the evaluation from four fee-for-service physicians. 
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The clinical and community observations 
from the other sites, which have not been 
formally evaluated, were consistent with the 
health improvements reported here.
Data were extracted from an electronic 
medical system during the most active peri-
ods of the interventions; this was early 2010 
to 2011 for S1, while for S2 anthropometric 
data were retrieved beginning in early 2012. 
For S1, where cardiometabolic data were 
available, baseline data were sought no ear-
lier than January 2008. The time between 
the first and last weighing was used to define 
the time spent in the LI by participants at 
S1, as participants were weighed at each 
meeting. Intensity of participation in the LI 
was calculated by dividing the months in 
the programme by the number of visits. We 
used International Diabetes Federation crite-
ria[4] to classify participants as having meta-
bolic syn drome (MetS). A haemoglobin A1c 
(HbA1c) measurement was used to indicate 
the presence of diabetes, in accordance with 
local clinical protocols.
Differences between anthropometric and 
biochemical variables were calculated, and 
paired t-tests were used to assess whether 
baseline values were statistically different 
to those at follow-up. Owing to the small 
sample size of individuals with HbA1c 
measurements (n=18), the Wilcoxon signed-
rank test was used to test whether follow-
up values were significantly different from 
baseline. We used multivariable analysis to 
examine the predictors of changes in body 
mass index (BMI) between baseline and 
follow-up in participants at S1. All statistical 
analyses were conducted on SAS version 9.2 
(SAS Institute, USA).
Results
This study documented the creation and 
repli cation of a successful LI in rural British 
Columbia (BC). We evaluated health imp-
rove ments among 372 participants at two 
physician-led interventions in a service 
contract (S1) and a fee-for-service practice 
context (S2); 139 participants were evaluated 
at S1 and 233 at S2, which began 2 years 
after the creation of the LI model at S1 
(Tables 1 and 2). Participants at both sites 
were mainly women (~80%), with a mean 
age of 52 (standard deviation (SD) 13) 
years and 51 (SD 14) years for S1 and S2, 
respec tively. Participants ranged in age from 
16 to 85 years. Additional measures were 
available from participants at S1, including 
cardiometabolic indicators (n=119) and 
mood scores (n=111). More than 90% of 
participants had a high waist circumference, 
while the average baseline BMI was 37 kg/
m2. Consistent with the high prevalence 
of  obesity, 57.6% (80/139) of participants 
began the intervention at S1 with MetS while 
12.9% (18/139) had T2DM.
Participants in these LIs had unusually 
large improvements in health, particularly 
given the real-world contexts of the 
interventions. For example, 372 participants 
had weight loss of >12% (Fig. 1), while in 
the Diabetes Prevention Program, a well-
resourced trial, the weight-loss goal was 7% 
of initial body weight. Among other studies 
examining LIs in routine practice, average 
weight loss was 3 - 5% at year 1.[2]
Consistent with the considerable weight 
loss, participants at S1 showed marked 
improve ments in their cardiometabolic pro-
file. For example, blood triglyceride concen-
trations, measured among 119 participants 
at S1, decreased by 34%, probably a reflec-
tion of the reduced intake of starches and 
sugars.[3] Among the 18 individuals with 
T2DM in the LI at S1, there was a mean 
decrease in HbA1c of 0.5%, a figure that fails 
to account for any reductions in pharmaco-
therapy, which were not documented in this 
report. The extent of the changes in cardio-
metabolic indicators that were measured in 
this study are therefore a conservative esti-
mate of the health improvements, as partici-
pants experienced reductions in the use of 
Table 1. Characteristics at baseline and follow-up of participants at S1 in a service 
contract primary care practice in rural BC, Canada (N=139)
Characteristic Baseline Follow-up Change p-value
Age (years), mean (SD) 52.4 (13.1) - - -
Sex, % female 80.4 - - -
Height (m), mean (SD) 1.7 (0.1) - - -
Weight (kg), mean (SD) 97.2 (22.6) 84.2 (20.6) –12.8 (8.9) <0.0001
BMI (kg/m2), mean (SD) 35.4 (7.0) 30.7 (6.4) –4.7 (3.2) <0.0001
% with elevated waist circumference 90.7 66.2 –24.5 <0.0001
% with metabolic syndrome 57.6 19.4 –38.2 <0.0001
% with PHQ-9 score ≥10 23.7 7.9 –15.8 <0.0001
PHQ-9 score (n=111), mean (SD) 7.0 (5.2) 3.4 (4.6) –3.6 (4.6) <0.0001
Blood pressure (mmHg, n=119), mean (SD) 136.6/85.4 122.5/77.0 –14.1/8.4 <0.0001
HDL-C (mmol/L, n=119), mean (SD) 1.34 (0.35) 1.42 (0.35) 0.08 (0.27) 0.0019
LDL-C (mmol/L), mean (SD) 3.31 (1.04) 2.90 (0.88) –0.41 (0.97) <0.0001
Triglyceride concentration (mmol/L), 
mean (SD)
1.63 (0.80) 1.08 (0.59) –0.56 (0.64) <0.0001
Triglyceride/HDL-C ratio, mean (SD) 1.36 (0.91) 0.84 (0.73) –0.52 (0.77) <0.0001
Fasting blood glucose concentration 
(mmol/L, n=111), mean (SD)
5.91 (1.74) 5.32 (1.17) –0.59 (1.47) <0.0001
HbA1c concentration (%, n=18), mean (SD) 7.47 (1.64) 6.95 (1.09) –0.52 (1.91) 0.089
HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol.
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Fig. 1. Weight loss (%) among participants in LIs in two primary care practices in rural British 
Columbia, Canada (N=372).
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insulin and oral hypoglycaemic, antihyper-
tensive and cholesterol-lowering agents. To 
the intervention participants, the reductions 
in pharmacotherapy were an empowering 
‘side-effect’ of the intervention, and for the 
clinicians administering the intervention, 
use of this therapeutic approach improved 
control of hyperglycaemia, hypertension and 
dyslipidaemias.
Similar to the findings of others,[5,6] we 
documented improvements in mood among 
participants in the intervention at S1 (n=111). 
Among the 32 participants with mood 
scores indicative of depression (PHQ-9 score 
≥10), the mean decrease in score was 7.0 
(SD 5.2). It was not possible to separate 
the effect of participating in group sessions 
from the physiological effects of the LI, as 
both these exposures are probably associ-
ated with improvements in mood. The mood 
improvements associated with weight loss 
may be attributable to reductions in patho-
physiological processes such as inflamma-
tion and hypothalamic-pituitary-adrenal axis 
activation that are common to both insulin 
resistance and mood disorders.[7]
We examined the predictors of weight 
change among participants at S1 using 
multivariable analysis (Table 3). We found 
that each visit per month increase in the LI 
was associated with a 0.7 kg/m2 greater loss 
in BMI after controlling for sex, age, baseline 
BMI and time spent in the programme. 
The importance of intensity of participation 
was reaffirmed in regression analysis by 
using change in weight per month as the 
dependent variable. These findings highlight 
the importance of group support in 
achieving therapeutic goals. Moreover, the 
clinical observation prior to the creation of 
the LI model was that one-on-one lifestyle 
counselling was less effective in producing 
lifestyle changes than participation in 
support groups. The effectiveness of support 
groups in the context of LIs has been 
documented previously[8] and may indicate 
the contribution of food addictions to these 
conditions.[9]
Conclusions
We documented the creation of an LI model 
and the replication of this intervention in 
different rural practices. This intervention 
was a powerful wellness tool, empowering 
not only patients[10] and physicians but the 
rural communities, which can be burdened 
with a high prevalence of chronic disease.
The intervention model documented 
in this study differed from the consensus 
prescription for LIs. For example, participants 
in this intervention were counselled to 
restrict moderate to vigorous physical 
activity while on the weight-loss diet; in 
contrast, in two highly cited randomised 
trials, participants were encouraged to 
undertake 150[1] and 175[11] minutes per week 
of moderate physical activity, respectively. 
More controversially, our intervention used 
a high-fat diet for weight maintenance, while 
in the Diabetes Prevention Program and 
the Look AHEAD trials, participants were 
counselled to avoid consuming foods rich in 
dietary fat. These conflicting prescriptions 
allude to a state of uncertainty that exists 
with regard to the optimal prescription for 
LIs for individuals with insulin resistance. 
This situation persists despite decades-old 
findings by Reaven (Garg et al.[12]) showing 
that insulin resistance is fundamentally a 
disorder of carbohydrate metabolism.
Given the magnitude of the obesity and 
diabetes pandemics, there is a public health 
imperative to provide practitioners with evi-
dence that supports effective interventions. 
While well-resourced randomised trials are 
powerful analytical tools, rigorous trials 
take decades to yield results and are argu-
ably prohibitively expensive. [13] Moreover, 
study results often lack generalisability to 
routine practice. [14] In contrast, the quality 
improvement process used in this study was not 
only powerful, as evidenced by the replication 
of the intervention model at four different 
practice sites, but offers a more expeditious 
way to spread effective interventions for 
obesity and insulin resistance.
Despite the rigour of our quality improve-
ment process, our efforts to communicate 
the merits of this intervention to health 
system administrators met with a frustrating 
lack of uptake. This is not surprising, given 
that the research literature has many com-
peting ‘solutions’ for the epidemics of obesity 
and diabetes,[15] many of which are difficult 
to falsify.[16] To support health administra-
tors in making evidence-based decisions, a 
broader set of data sources could be used to 
evaluate health system interventions such 
as that documented here. For example, the 
Institute of Health Improvement recom-
mends using indicators that measure patient 
satisfaction, health system cost and popula-
tion health status,[17] complementing data 
from physician records. A broader set of 
health system indicators combined with lon-
ger-term follow-up of intervention partici-
pants would enable evidence-based health 
system decision-making in a climate of fiscal 
restraint.
Taken as a whole, our evidence suggests 
that a timely response to the obesity and dia-
betes pandemics requires a critical re think 
not only of the current evidence base under-
pinning LIs, but also of the systems with 
which evidence is generated and integrated 
into health system practice.
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